111 (YI) Net Cash Flow (QoQ) (2017 - 2025)
111 (YI) Net Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137.26% |
| Sep 30, 2025 | 134.49% |
| Jun 30, 2025 | -212.05% |
| Mar 31, 2025 | 183.72% |
| Dec 31, 2024 | -190.30% |
| Sep 30, 2024 | 156.03% |
| Jun 30, 2024 | -422.68% |
| Mar 31, 2024 | 87.45% |
| Dec 31, 2023 | -192.28% |
| Sep 30, 2023 | 1,784.76% |
| Jun 30, 2023 | 91.22% |
| Mar 31, 2023 | -190.75% |
| Dec 31, 2022 | -147.83% |
| Sep 30, 2022 | 188.80% |
| Jun 30, 2022 | -610.29% |
| Mar 31, 2022 | -116.10% |
| Dec 31, 2021 | 117.99% |
| Sep 30, 2021 | -473.00% |
| Jun 30, 2021 | 127.09% |
| Mar 31, 2021 | -276.55% |